Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contacts | Login 
  Users Online: 1086 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

  Article Access Statistics

Year : 2021 | Volume:  11 | Issue Number:  1 | Page:  1-7

REVIEW ARTICLE

Firibastat, the first-in-class brain aminopeptidase a inhibitor, in the management of hypertension: A review of clinical trials
Alomar Sara Abdulrahman, Alghabban Sarah Ali, Alharbi Hadeel Abdulaziz, Almoqati Mehad Fahad, Alduraibi Yazid, Abu-Zaid Ahmed

Number of times this article was viewed 1342
Number of times this article has been printed  from the site 8
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 
  Feedback 
  Subscribe 
 Back To Article

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal
Sitemap | What's New | Feedback | Disclaimer |  
© Avicenna Journal of Medicine | Published by Wolters Kluwer - Medknow
Online since 05 February, 2011